The central role of platelets in both physiological hemostasis and pathological thrombosis means that platelet activation must be tightly controlled. Blood vessel damage or atherosclerotic plaque rupture exposes subendoethial matrix proteins, in particular collagens, to flowing blood, leading to platelet adhesion and activation (1, 2) . Activated platelets expose phosphatidylserine (PS), 2 which is an efficient surface for assembly of the tenase (FIXa/VIIIa) and prothrombinase (FXa/Va) complexes (3) , generating a burst of thrombin that is responsible for producing a stable hemostatic clot or an occlusive thrombus.
PS-exposing platelets are essential to thrombus growth in arterioles and, to a lesser extent, in venules (4) . Restricting platelet PS exposure may therefore restrict thrombus growth.
A rise in intracellular calcium concentration ([Ca 2ϩ ] i ) is required for many platelet responses. Sustained Ca 2ϩ signaling is required for platelets to expose PS and accelerate thrombin generation (5) (6) (7) (8) . Loss of plasma membrane asymmetry takes several minutes, so a sustained increase in intracellular Ca 2ϩ is required. If [Ca 2ϩ ] i is restored to basal levels, membrane asymmetry can be restored (9) . Tight control of Ca 2ϩ signaling therefore closely regulates PS exposure and platelet-dependent thrombin generation, and any factor that negatively regulates sustained Ca 2ϩ signaling may reduce PS exposure and limit occlusive thrombus development.
Most platelet activators induce Ca 2ϩ release from intracellular Ca 2ϩ stores via the second messenger, inositol 1,4,5-trisphosphate (10) . The initial transient increase in [Ca 2ϩ ] i due to Ca 2ϩ release is amplified Ca 2ϩ entry from the extracellular medium. Ca 2ϩ entry is also likely to be required to provide a sufficiently sustained signal to induce prolonged PS exposure, because agonist-induced Ca 2ϩ release is usually transient (11) . Store-operated Ca 2ϩ entry (SOCE), a major pathway for Ca 2ϩ entry into platelets and other nonexcitable cells, is activated by a decrease in the Ca 2ϩ content of the intracellular Ca 2ϩ stores (12) (13) (14) . Platelets also express at least one store-independent Ca 2ϩ entry pathway, activated by diacylglycerol (DAG) (15) . The relative contributions of these different Ca 2ϩ entry pathways to agonist-induced Ca 2ϩ signaling and Ca 2ϩ -dependent platelet responses, in particular PS exposure, are less well understood. Moreover, how Ca 2ϩ signaling is regulated during platelet activation, to provide sufficient signal without excessive PS exposure, is not known.
Protein kinase C (PKC) isoforms have long been known to play important roles in platelet activation. Although often considered a positive regulator of platelet activation, PKC may also negatively regulate some signaling events (16) . In particular, it has been suggested that PKC negatively regulates platelet Ca 2ϩ signaling (17) . We have previously reported that the novel PKC isoform, PKC, negatively regulates platelet activation downstream of the major collagen receptor, glycoprotein VI (GPVI), with PKC Ϫ/Ϫ platelets displaying enhanced collagen-related peptide (CRP)-induced integrin activation (18) and granule secretion (19) at low agonist concentrations. Here, we have investigated whether PKC regulates GPVI-dependent Ca 2ϩ signaling in mouse platelets. In particular, we report that PKC negatively regulates store-independent Ca 2ϩ entry, which leads to higher sustained [Ca 2ϩ ] i levels in PKC Ϫ/Ϫ platelets and enhanced PS exposure, revealing a novel mechanism by which platelet procoagulant activity may be tightly controlled.
EXPERIMENTAL PROCEDURES
Materials-Unless stated, all materials were from Sigma and were of analytical grade. Cross-linked CRP was from Professor Richard Farndale (Biochemistry, University of Cambridge, UK). Fura-PE3 was from TefLabs (Austin, TX). Annexin V-fluorescein isothiocyanate was obtained from Abcam (Cambridge, UK). Bisindolylmaleimide I (BIM), LOE-908, and MRS-2279 were from Tocris Bioscience (Bristol, UK). AR-C69931M-X was a kind gift from AstraZeneca.
Mice-PKC Ϫ/Ϫ C57B6/J mice have been previously described (20) . No compensatory change in expression of other PKC isoforms has been observed in PKC Ϫ/Ϫ platelets (18), and we have found no differences in GPVI surface expression between PKC Ϫ/Ϫ and WT platelets (data not shown). Wildtype C57B6/J mice were used as control. Use of mouse platelets was approved by local research ethics committee at the University of Bristol, UK, and mice were bred for this purpose under UK Home Office license (PPL 30/2386) held by A. W. P.
Preparation of Fura-PE3-loaded Mouse Platelets-Washed mouse platelets were prepared essentially as described previously (21) and suspended in a modified Tyrode's/HEPES buffer (134 mM NaCl, 0.34 mM Na 2 HPO 4 , 2.9 mM KCl, 12 mM NaHCO 3 , 20 mM HEPES, 5 mM glucose, and 1 mM MgCl 2 , pH 7.3) supplemented with 0.35% bovine serum albumin, 1 M prostaglandin E 1 , 10 M indomethacin, 0.02 units/ml apyrase (grade VII)). Platelets were incubated with Fura-PE3 (3 M) for 30 min at room temperature. Acid citrate dextrose (20 mM citric acid, 110 mM sodium citrate, 5 mM glucose) was added (1:9), and platelets were collected by centrifugation and resuspended in modified HEPES/Tyrode's, supplemented with indomethacin and apyrase, to a concentration of 1 ϫ 10 8 platelets/ml. 
, where S 0 and S s are the fluorescence at 380 nm in the absence of Ca 2ϩ and in saturating Ca 2ϩ , respectively (22) , and K d ϭ 290 nM (23) . Where indicated, the area under the Ca 2ϩ trace (AUC) above basal was calculated for 3 min after stimulation. For store-operated Ca 2ϩ entry, AUC was calculated for 3 min after re-addition of Ca 2ϩ (see Fig. 3A ), corrected by subtraction of the increase in fluorescence due to leaked Fura-PE3.
Mn 2ϩ Quench as a Marker of Divalent Cation Entry-Platelets were stimulated in the presence of MnCl 2 (100 M) and CaCl 2 (1 mM), and fluorescence was monitored at an excitation wavelength of 360 nm. As with Fura-2 (24) , at this wavelength Fura-PE3 fluorescence is insensitive to changes in Ca 2ϩ concentration but is quenched by Mn 2ϩ . Autofluorescence was subtracted from the fluorescence intensity, which was then normalized to initial fluorescence intensity (F/F 0 ). The extent of decrease 3 min after stimulation was measured and corrected by subtraction for the decrease in fluorescence due to Mn 2ϩ or dye leakage (monitored as the quench in the absence of agonist over the same time period).
Flow Cytometry-Annexin V-fluorescein isothiocyanate was used to detect surface PS exposure. Platelets (5 ϫ 10 7 /ml) were stimulated in the presence of CaCl 2 (2 mM) for 10 min. Annexin V binding was detected by flow cytometry, with platelets gated by their forward and side scatter profile. Analysis of 20,000 platelets was performed using a FACSCalibur (BD Biosciences). Data were analyzed using WinMDI version 2.8.
Statistical Analyses and Data Presentation-Where presented, mean data are given Ϯ S.E. Statistical significance was determined by two-way analysis of variance with Bonferroni post-test, performed using Prism 4.0 (GraphPad Software). p Ͻ 0.05 was considered significant.
RESULTS

PKC Negatively Regulates CRP-induced Ca
2ϩ Signaling and PS Exposure-The role of PKC in GPVI-dependent Ca 2ϩ signaling was investigated in Fura-PE3-loaded and washed mouse platelets. The platelets were treated with indomethacin (10 M) to prevent any thromboxane generation, because this may also be regulated by PKC (25) .
A low concentration of the GPVI-selective agonist, CRP (1 g/ml), induced an increase in [Ca 2ϩ ] i in wild-type (WT) platelets, which reached a peak within 2 min and then declined toward a sustained level (Fig. 1A) . In PKC Ϫ/Ϫ platelets, the peak increase was significantly greater than seen in WT (363 Ϯ 42 nM above basal in PKC Ϫ/Ϫ compared with 236 Ϯ 24 nM in WT; n ϭ 4; p Ͻ 0.01). Furthermore, the sustained [Ca ] i was 158 Ϯ 19 nM above basal, 5 min after stimulation, compared with 46 Ϯ 8 nM in WT; n ϭ 4; p Ͻ 0.001). These data indicate that PKC negatively regulates GPVI-dependent Ca 2ϩ signaling. We have previously shown that CRP-induced granule secretion is greater in PKC Ϫ/Ϫ platelets, under some conditions (18, 19) . To test whether enhanced ADP secretion could explain the enhanced Ca 2ϩ signal, platelets were treated with MRS-2279 (10 M) and AR-C69931M-X (1 M), antagonists of P2Y 1 and P2Y 12 , respectively. Although P2Y antagonism abolished the enhancement in peak Ca 2ϩ increase (Fig. 1 , B and C), [Ca 2ϩ ] i was still sustained at a greater level in PKC Ϫ/Ϫ platelets ( ] i level. PS exposure on the platelet surface forms an assembly site for coagulation complexes and accelerates thrombin generation. PS exposure requires a sustained increase in [Ca 2ϩ ] i . CRP induced a proportion of WT platelets to expose PS (9.8 Ϯ 2.9% were stained positively with annexin V; n ϭ 9). This proportion was doubled in PKC Ϫ/Ϫ platelets (21.5 Ϯ 2.5%; n ϭ 9; Fig. 1E ). Consistent with these data, pretreatment of WT platelets with the broad spectrum PKC inhibitor BIM (10 M) increased the proportion of annexin V-positive platelets (21.3 Ϯ 2.7%; n ϭ 4). In contrast, BIM had no additional effect on PKC Ϫ/Ϫ platelets (21.0 Ϯ 4.6%; n ϭ 4; Fig. 1F ).
Pretreatment with MRS-2279 and AR-C69931M-X partially reduced annexin V binding in WT platelets (6.8 Ϯ 2.9% were annexin V-positive; n ϭ 4). Even with P2Y1/P2Y12 blockade, however, annexin V binding was significantly enhanced in (Fig. 3A) . However, P2Y antagonists blocked the apparent enhancement, suggesting that enhanced ADP secretion was responsible for this, rather than a direct effect on SOCE itself (Fig. 3, B and C) . Furthermore, these data suggest PKC may instead regulate a store-independent Ca 2ϩ entry pathway. PKC Negatively Regulates Store-independent Ca 2ϩ EntryStore-independent Ca 2ϩ entry pathways (also known as noncapacitative Ca 2ϩ entry) have been described in many cells, including platelets (15) . In many cells, Ca 2ϩ entry can be directly activated by DAG analogues, such as OAG. In WT platelets, OAG (20 M) induced a sustained increase in [Ca 2ϩ ] i (Fig. 4A) that was unaffected by P2Y blockade (Fig. 4B) . OAGinduced Ca 2ϩ entry was significantly greater in PKC Ϫ/Ϫ platelets (Fig. 4A) but also unaffected by P2Y antagonists (Fig. 4B) . Furthermore, OAG-induced Mn 2ϩ entry was enhanced in PKC Ϫ/Ϫ platelets independently of P2Y signaling (Fig. 4, C store-independent Ca 2ϩ entry (Fig. 5A ),but at this concentration has no effect on SOCE (Fig. 5B) . LOE-908 significantly reduced the CRP-induced Ca 2ϩ signal in WT platelets, although the sustained [Ca 2ϩ ] i level reached after 5 min was not affected (Fig. 5, C and D) . Importantly, the Ca 2ϩ signal was no different between WT and PKC Ϫ/Ϫ platelets in the presence of LOE-908 (Fig. 5C) , p Ͼ 0.05; Fig.  5E ). These data are summarized in Fig. 5F . These data strongly suggest that PKC negatively regulates CRP-induced Ca 2ϩ sig- naling by reducing store-independent Ca 2ϩ entry, which in turn reduces platelet PS exposure.
DISCUSSION
In this study we have shown that PKC negatively regulates GPVI-dependent Ca 2ϩ signaling, leading to reduced PS exposure. The negative regulation occurs at two distinct points as follows: 1) negative regulation of dense granule secretion and subsequent ADP-dependent Ca 2ϩ release; 2) negative regulation of store-independent Ca 2ϩ entry. We suggest that under normal conditions, store-independent Ca 2ϩ entry contributes to the initial, transient increase in [Ca 2ϩ ] i but is then downregulated by PKC. This limits the sustained increase in [Ca 2ϩ ] i and so reduces PS exposure. This is represented in Fig. 6 . The work therefore reveals a novel pathway for regulation of platelet Ca 2ϩ signaling and procoagulant activity, which plays a key role in thrombus growth.
We have previously shown that PKC negatively regulates GPVI-dependent platelet activation (18) . Here, we were first able to show that GPVI-dependent Ca 2ϩ signaling is greater in amplitude and sustained at a higher level in PKC Ϫ/Ϫ platelets. The more sustained Ca 2ϩ signal is associated with a PS exposure in a greater proportion of cells. The normal function of PKC therefore may be to limit GPVI-dependent Ca 2ϩ signaling and so restrict PS exposure and platelet procoagulant activity during thrombus formation. The sustained Ca 2ϩ signal was not entirely due to enhanced ADP secretion. We have previously demonstrated that, under some conditions, CRP-induced dense granule secretion is enhanced in PKC Ϫ/Ϫ platelets (19) (although this is partly dependent on assay conditions and agonist concentration). However, Ca 2ϩ signaling was sustained at a higher level in PKC Ϫ/Ϫ platelets even in the presence of P2Y receptor antagonists, indicating that ADP signaling was not required. (28) . Although we found that thapsigargin-activated SOCE was enhanced in PKC Ϫ/Ϫ platelets, it is known that part of the apparent SOCE signal may in fact be due to dense granule release (29) . When the contribution of autocrine P2Y signaling was blocked, SOCE was not significantly different between PKC Ϫ/Ϫ and WT platelets. This indicates that SOCE is not directly regulated by PKC. Rather, increased dense granule secretion may further enhance Ca 2ϩ release and store depletion, leading to greater SOCE. These data suggest that the negative regulation of CRP-induced Ca 2ϩ entry is not through regulation of SOCE. Ca 2ϩ entry can occur through store-independent pathways, although much less is known about these pathways in platelets. In common with many cells, DAG analogues induce Ca 2ϩ entry in platelets (15) . Interestingly, this Ca 2ϩ entry was enhanced in PKC Ϫ/Ϫ platelets. Furthermore, unlike SOCE, this enhancement was seen in the presence of P2Y antagonists. This means that OAG-activated, store-independent Ca 2ϩ entry pathway is directly regulated by PKC, whereas SOCE is not.
OAG-induced Ca 2ϩ entry pathway was blocked by LOE-908, whereas SOCE was unaffected by this drug. This makes LOE-908 a useful tool to discriminate between different Ca 2ϩ entry pathways during platelet activation. LOE-908 significantly reduced CRP-induced Ca 2ϩ signaling. In WT platelets, LOE-908 reduced the initial Ca 2ϩ signal but not the sustained signal. This suggests that normally, store-independent Ca 2ϩ entry amplifies the initial response but is not involved in the sustained Ca 2ϩ signal. Importantly, in the presence of LOE-908, PKC Ϫ/Ϫ platelets showed identical Ca 2ϩ signaling to WT, indicating that the enhanced response requires store-independent Ca 2ϩ entry. We conclude, therefore, that PKC negatively regulates store-independent Ca 2ϩ entry following stimulation of GPVI and that normally (i.e. in WT cells) store-independent Ca 2ϩ entry is not involved in the sustained response because it has been switched off by PKC.
Negative regulation of store-independent Ca 2ϩ entry by PKC has been proposed in some cultured cell lines (30) , although, to the best of our knowledge, this is the first report that describes regulation of store-independent Ca 2ϩ entry by a specific PKC isoform in a native cell type. The mechanism of regulation by PKC is still unclear. TRPC3, which may form part of storeindependent channels in some cells (although its expression in platelets is uncertain (31, 32) ), is phosphorylated at Ser-712 in a PKC-dependent manner in HEK-293 cells (33) , which leads to inhibition of TRPC3. The store-independent channel in platelets, yet to be unambiguously identified, may also be directly phosphorylated. Alternatively, PKC may act indirectly, for example by modulating channel expression in the plasma membrane (34, 35) .
SOCE is commonly considered to provide the majority of Ca 2ϩ entry in nonexcitable cells (12) . This view is strengthened by the large reduction in Ca 2ϩ signaling in Orai1 Ϫ/Ϫ platelets, in which SOCE is almost completely abolished (36) . In contrast, LOE-908, which does not affect SOCE under the conditions used in this study, significantly reduced CRP-induced Ca 2ϩ signaling. The effect of LOE-908 was restricted to the earlier portion of the Ca 2ϩ signal, whereas the sustained [Ca 2ϩ ] i was unaffected. These data suggest that the importance of different Ca 2ϩ entry pathways may be temporally controlled, with DAGactivated/store-independent Ca 2ϩ entry contributing to the early peak and SOCE more important for sustained Ca 2ϩ signaling. Our data suggest that one mechanism behind this temporal control is PKC, which may "switch off" store-independent Ca 2ϩ entry (see Fig. 6 ). The major functional consequence of this negative regulation of store-independent Ca 2ϩ entry may be to limit platelet PS exposure, which is a key component of thrombin generation during vascular damage. Although tissue factor-exposing cells initiate thrombin generation through the extrinsic coagulation cascade, propagation of thrombin generation occurs on PS-exposing platelets (3). Platelets provide an efficient and regulated procoagulant surface because they are localized to sites of vascular injury and can coordinate assembly of the tenase and prothrombinase complexes. Furthermore, inhibition of these coagulation complexes by plasma protease inhibitors is less effective when the proteases are on cell surfaces than when they are in solution (3) . Central in inducing PS exposure is a sustained increase in [Ca 2ϩ ] i (9, 37, 38) . Our data suggest that PKC negatively regulates this process by inhibiting store-independent Ca 2ϩ entry and so reducing [Ca 2ϩ ] i . Importantly, this regulation appears to be the normal situation, because LOE-908 had little effect on PS exposure in WT platelets, despite the large inhibition of the earlier phase of the Ca 2ϩ signal. Interestingly, LOE-908 reduced infarct volume following focal cerebral ischemia in a rat middle cerebral artery occlusion model of stroke (39, 40) , highlighting the importance of controlling store-independent Ca 2ϩ entry. We have previously reported that PKC negatively regulates GPVI-dependent granule secretion, integrin activation, and thrombus formation on collagen (18) . In contrast, another group has reported that PKC positively regulates GPVI-dependent granule secretion, integrin activation, and platelet aggregation (25) . With regards to granule secretion, this may reflect agonist concentration (with negative regulation seen at low CRP concentrations by both groups (19) ). The alterations in integrin activation are likely to be related to changes in dense granule secretion, because P2Y 12 is a major regulator of integrin activation (41) . It is important to stress, however, that these previous studies were performed in the absence of extracellular Ca 2ϩ , and so the novel regulation of store-independent Ca 2ϩ entry that we describe here cannot account for the regulation of granule secretion. Rather, PKC is likely to regulate granule secretion and Ca 2ϩ entry through distinct mechanisms. In summary, we have identified a novel role for PKC in reducing GPVI-dependent Ca 2ϩ signaling and PS exposure. This is mediated by reduced Ca 2ϩ entry through a store-independent Ca 2ϩ channel. Because platelet PS exposure is a key determinant of thrombin generation and thrombus formation, PKC may act to limit collagen-dependent thrombin generation and hence occlusive thrombus formation at sites of vascular injury.
